Stroke Research

Stroke is classified as both a neurological and a cardiovascular disease, as it is a disruption in blood supply to the brain which causes the neurological abnormalities. There are two types of stroke; ischemic and hemorrhagic.

Stroke Research Products Targets

Products for Stroke Research - Page 60

  1. Cat.No. Product Name Information/Activity
  2. BCC4784 Glyburide Glibenclamide is a selective inhibitor of ATP-sensitive K+ channel. Glyburide chemical structure
  3. BCC2109 Glimepiride Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. Glimepiride chemical structure
  4. BCC5006 ML133 HCl ML133 hydrochloride is a selective Kir2 family channels inhibitor, with an IC50 of 1.8 μM at pH 7.4 and 290 nM at pH 8.5. ML133 HCl chemical structure
  5. BCC5005 Nateglinide Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K+ channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus[1][2]. Nateglinide chemical structure
  6. BCC7262 PNU 37883 hydrochloride 57568-80-6 PNU 37883 hydrochloride chemical structure
  7. BCC2504 Repaglinide Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus. Repaglinide chemical structure
  8. BCC6849 SCH 23390 hydrochloride SCH-23390 hydrochloride (R-(+)-SCH-23390 hydrochloride) is a potent and selective dopamine D1-like receptor antagonist with Kis of 0.2 nM and 0.3 nM for the D1 and D5 receptor, respectively. SCH-23390 hydrochloride is a potent and high efficacy human 5-HT2C receptor agonist with a Ki of 9.3 nM. SCH-23390 hydrochloride also binds with high affinity to the 5-HT2 and 5-HT1C receptors. SCH-23390 hydrochloride inhibits G protein-coupled inwardly rectifying potassium (GIRK) channels with an IC50 of 268 nM. SCH 23390 hydrochloride chemical structure
  9. BCC3866 Terfenadine Terfenadine ((±)-Terfenadine) is a potent open-channel blocker of hERG with an IC50 of 204 nM. Terfenadine, an H1 histamine receptor antagonist, acts as a potent apoptosis inducer in melanoma cells through modulation of Ca2+ homeostasis. Terfenadine induces ROS-dependent apoptosis, simultaneously activates Caspase-4, -2, -9. Terfenadine chemical structure
  10. BCC5740 Tertiapin-Q 252198-49-5 Tertiapin-Q chemical structure
  11. BCC6126 VU 591 hydrochloride VU591 hydrochloride is a potent, selective renal outer medullary potassium channel (ROMK or Kir1.1) inhibitor, with an IC50 of 0.24 μM. VU 591 hydrochloride chemical structure

Items 591 to 600 of 665 total